-, Sodium butyrate 1,1 g/L sol prep
RCAPHM18_0018
Phase 3 small_molecule active
Quick answer
-, Sodium butyrate 1,1 g/L sol prep for Hirschsprung's disease is a Phase 3 program (small_molecule) at ISTA Pharma Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ISTA Pharma Limited
- Indication
- Hirschsprung's disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active